This is a multi-site, observational, prospective test negative design case-control studywhich primarily aims to determine the protective effectiveness of 2 doses of aninactivated COVID-19 vaccine at least 14 days after the second dose, against hospitalizedvirologically-confirmed SARS-CoV-2 infection.
Not Provided
Other: no intervention
no intervention
Inclusion Criteria:
- Written informed consent.
- Aged 18 years of age and above
- Residing in the catchment area of the participating hospital
- Admitted to the participating hospital with an acute respiratory illness
- Able and willing to provide a naso- and oro-pharyngeal swab for RT-PCR testing
Exclusion Criteria:
- 6.2.2.1 Refusal to participate
Vicente Sotto Memorial Medical Center
Cebu City, Cebu Province, Philippines
Investigator: Kristal An Agrupis
Contact: +639173668540
kcagrupis@up.edu.ph
Kristal An C Agrupis, MD, MSc
+63 2 8559 0199
kcagrupis@up.edu.ph